FIELD: medicine, dermatology. SUBSTANCE: invention relates to novel forms of dimocifon. Invention proposes dimocifon as capsules or ointment containing active substance in the dose 0.05-0.2 g and 2-5 wt.%, respectively. Invention provides reduction of preparation amount doses up to 1-2 times per a week due to the prolonged therapeutic effect and significant decrease of adverse effects: nausea, reflux, dyspeptic symptoms, hepatitis. EFFECT: enhanced effectiveness of medicinal form, improved medicinal properties. 2 cl, 3 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
N,N'-(SULFONYLDI-1,4-PHENYLENE)-BIS-(N'',N''-DIMETHYLFORM- -AMIDINE)-1,2,3,4-TETRAHYDRO-6-METHYL-2,4-DIOXO-5-PYRIMIDINE SULFONATE STIMULATING CELLULAR METABOLISM AND SHOWING IMMUNOTROPIC AND ANTIBACTERIAL ACTIVITY | 1997 |
|
RU2136668C1 |
N-(6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5H-PYRIMIDINESULFONE)-N′- ISONICOTINOYL HYDRAZIDE DISODIUM SALT ELICITING ANTIBACTERIAL AND IMMUNOTROPIC ACTIVITY AND MEDICINAL AGENT BASED ON THEREOF | 1999 |
|
RU2191015C2 |
IMMUNOMODULATING AGENT "IZOFON" SHOWING ANTIMYCOBACTERIAL ACTIVITY, METHOD OF ITS PREPARING AND USING | 1997 |
|
RU2141322C1 |
OROTATE OF N, П,П'-DIAMINODIPHENYL SULFONE HAVING ANTILEPROSOUS AND IMMUNOTROPIC ACTIVITY | 1995 |
|
RU2074856C1 |
PHARMACEUTICAL COMPOSITION FOR ATOPIC DERMATITIS | 2010 |
|
RU2453303C1 |
VETERINARY MEDICINAL PRODUCT WITH ANTI-INFLAMMATORY, ANTIPRURITIC AND REGENERATIVE ACTION IN INFLAMMATORY SKIN DISEASES | 2014 |
|
RU2650649C2 |
METHOD OF TREATING VIDAL'S DISEASE | 2008 |
|
RU2396963C1 |
BIOLOGICALLY ACTIVE SUPPLEMENT "KOZHNYE" | 2002 |
|
RU2238101C2 |
BIOLOGICALLY ACTIVE ADDITIVE "GIPO-ALLERGIN" | 2001 |
|
RU2190420C1 |
ISONICOTINIC ACID HYDRAZIDE OROTATE HAVING ANTIBACTERIAL AND IMMUNOTROPIC ACTIVITIES | 1990 |
|
RU2044728C1 |
Authors
Dates
2003-03-20—Published
1999-10-29—Filed